Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synageva BioPharma Corp Announces Pricing Of Public Offering Of Common Stock


Tuesday, 24 Sep 2013 07:45pm EDT 

Synageva BioPharma Corp announced the pricing of its previously announced underwritten public offering of common stock consisting of 2.75 million shares at $56.63 per share. In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase412,500 additional shares of common stock. If the underwriters exercise this option, Synageva will have offered approximately 3.16 million shares of its common stock. Goldman, Sachs & Co. is acting as the sole book-running manager in the offering. Morgan Stanley & Co., Cowen and Company, and Canaccord Genuity Inc. are acting as co-managers in the offering. 

Company Quote

95.46
0.46 +0.48%
19 Dec 2014